Observational studyBMC infectious diseases2026
Association between hypertension and sepsis-related complications: a retrospective nationwide inpatient sample database cross-sectional study.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSepsis remains a significant global health challenge, with high morbidity and mortality rates. The interplay between hypertension, a prevalent comorbidity, and sepsis outcomes has been the subject of ongoing debate. This study aimed to investigate the incidence of sepsis-related complications in individuals with and without hypertension via a large nationwide inpatient database.
methodsA retrospective observational analysis was conducted via the National Inpatient Sample (NIS) database from 2010 to 2019. The study population comprised adults (≥ 18 years) diagnosed with sepsis and stratified into hypertension and non-hypertension groups. The outcomes assessed included sepsis-related complications, in-hospital mortality, length of stay (LOS), and total hospitalization costs.
resultsThe prevalence of hypertension among sepsis patients increased significantly from 53.17% in 2010 to 64.62% in 2019. Patients in the hypertension group were older, with a greater proportion of individuals aged 75 years and above, and presented a greater burden of comorbidities. Interestingly, the hypertension group had lower incidences of septic shock, acute respiratory distress syndrome (ARDS), disseminated intravascular coagulation (DIC), and deep vein thrombosis (DVT), indicating a potential inverse association. However, they experienced higher rates of heart failure, acute kidney injury(AKI), arrhythmias, and acute respiratory failure. Despite these increased risks, the hypertension group had a shorter median LOS and lower median total hospital charges. Notably, the in-hospital mortality rate was lower in the hypertension group (11.93%) than in the nonhypertension group (13.33%).
conclusionThis large-scale analysis revealed a complex interplay between hypertension and sepsis outcomes. The observed lower incidence of certain severe sepsis complications among hypertensive patients suggests a potential association that might be partially related to the use of antihypertensive therapies, but this hypothesis requires further investigation into the underlying mechanisms. Our findings should be interpreted as associational, not causal. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.